Evidence-Based Review of the Use of Steroids in Neurotrauma

Chapter

Abstract

Traumatic brain injury is a leading cause of premature death and disability in the world. Post-traumatic inflammation and edema is poorly tolerated by the central nervous system and exacerbates neurologic deterioration. Local release of cytotoxic inflammatory mediations results in secondary injury and worsening clinical outcomes. To reduce post-traumatic inflammation, steroids have been investigated and used as a preventative measure. This chapter reviews the most up-to-date literature on steroid use for the treatment of traumatic brain and spinal cord injury as well as traumatic cranial neuropathies and make recommendations on its role in modern clinical practice.

Keywords

Steroids Spinal cord injury Traumatic brain injury Cranial nerve injury 

References

  1. 1.
    Fitch MT, Doller C, Combs CK, Landreth GE, Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci: The Official Journal of the Society for Neuroscience. 1999;19(19):8182–98.Google Scholar
  2. 2.
    van de Beek D, de Gans J, McIntyre P, Prasad K, Corticosteroids for acute bacterial meningitis. Cochrane Database Syst. Rev. 2007;(1):CD004405. PubMed PMID: 17253505.Google Scholar
  3. 3.
    van de Beek D. Corticosteroids for acute adult bacterial meningitis. Medecine et maladies infectieuses. 2009;39(7–8):531–8. PubMed PMID: 19386456.Google Scholar
  4. 4.
    Shane SJ, Riley C. Tuberculous meningitis: combined therapy with cortisone and antimicrobial agents. The New England journal of medicine. 1953;249(21):829–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Pierce CA, Hanks RA. Life satisfaction after traumatic brain injury and the World Health Organization model of disability. Am J Phys Med Rehabil Assoc Acad Physiatrists. 2006;85(11):889–98.CrossRefGoogle Scholar
  6. 6.
    Jennett B. Epidemiology of head injury. J Neurol Neurosurg Psychiatry. 1996;60(4):362–9. PubMed PMID: 8774396. Pubmed Central PMCID: 1073884.Google Scholar
  7. 7.
    Roberts I. China takes to the roads. Bmj. 1995;310(6990):1311–3. PubMed PMID: 7773048. Pubmed Central PMCID: 2549683.Google Scholar
  8. 8.
    Michaud C, Murray CJ. External assistance to the health sector in developing countries: a detailed analysis, 1972–90. Bulletin of the World Health Organization. 1994;72(4):639–51. PubMed PMID: 7923543.Google Scholar
  9. 9.
    White BC, Krause GS. Brain injury and repair mechanisms: the potential for pharmacologic therapy in closed-head trauma. Ann Emerg Med. 1993;22(6):970–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A systematic review of brain injury epidemiology in Europe. Acta neurochirurgica. 2006;148(3):255–68; discussion 68. PubMed PMID: 16311842.Google Scholar
  11. 11.
    Galicich JH, French LA, Melby JC. Use of dexamethasone in treatment of cerebral edema associated with brain tumors. The Journal-lancet. 1961;81:46–53.PubMedGoogle Scholar
  12. 12.
    Nelson SR, Mantz ML, Maxwell JA. Use of specific gravity in the measurement of cerebral edema. J Appl Physiol. 1971;30(2):268–71.PubMedGoogle Scholar
  13. 13.
    McEwen BS, Weiss JM, Schwartz LS. Retention of corticosterone by cell nuclei from brain regions of adrenalectomized rats. Brain Res. 1970;17(3):471–82.CrossRefPubMedGoogle Scholar
  14. 14.
    Dutka AJ, Mink RB, Pearson RR, Hallenbeck JM. Effects of treatment with dexamethasone on recovery from experimental cerebral arterial gas embolism. Undersea biomedical research. 1992;19(2):131–41.PubMedGoogle Scholar
  15. 15.
    Marescal C, Adnet P, Bello N, Halle I, Forget AP, Boittiaux P, Secondary cerebral stress of systemic origin in children with severe craniocerebral injuries. Ann Fr Anesth Reanim. 1998;17(3):234–9. PubMed PMID: 9750735. Agressions cerebrales secondaires d’origine systemique chez les enfants traumatises craniocerebraux graves.Google Scholar
  16. 16.
    Pereira WC, Neves VJ, Rodrigues Y, Bifrontal decompressive craniotomy as the treatment for severe cerebral edema. Arq Neuropsiquiatr. 1977;35(2):99–111. PubMed PMID: 869742. Craniotomia descompressive bifrontal no tratamento do edema cerebral grave.Google Scholar
  17. 17.
    Gobiet W, Fiebach O, Pneumoradiographic demonstration of a large cyst in Lindau’s tumor. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 1976;124(1):88–9. PubMed PMID: 130326. Pneumographische Darstellung einer grossen Zyste in einem Lindau-Tumor.Google Scholar
  18. 18.
    Renaudin J, Fewer D, Wilson CB, Boldrey EB, Calogero J, Enot KJ. Dose dependency of decadron in patients with partially excised brain tumors. J Neurosurg. 1973;39(3):302–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Alderson P, Roberts I, Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. BMJ. 1997;314(7098):1855–9. PubMed PMID: 9224126. Pubmed Central PMCID: 2126994.Google Scholar
  20. 20.
    Giannotta SL, Weiss MH, Apuzzo ML, Martin E. High dose glucocorticoids in the management of severe head injury. Neurosurgery. 1984;15(4):497–501.CrossRefPubMedGoogle Scholar
  21. 21.
    Saul TG, Ducker TB, Salcman M, Carro E. Steroids in severe head injury: a prospective randomized clinical trial. J Neurosurg. 1981;54(5):596–600.CrossRefPubMedGoogle Scholar
  22. 22.
    Braakman R, Schouten HJ, Blaauw-van Dishoeck M, Minderhoud JM, Megadose steroids in severe head injury. Results of a prospective double-blind clinical trial. J Neurosurg. 1983;58(3):326–30. PubMed PMID: 6338164.Google Scholar
  23. 23.
    Cooper PR, Moody S, Clark WK, Kirkpatrick J, Maravilla K, Gould AL, et al. Dexamethasone and severe head injury. a prospective double-blind study. J Neurosurg. 1979;51(3):307–16.CrossRefPubMedGoogle Scholar
  24. 24.
    Gudeman SK, Miller JD, Becker DP. Failure of high-dose steroid therapy to influence intracranial pressure in patients with severe head injury. J Neurosurg. 1979;51(3):301–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Gaab MR, Trost HA, Alcantara A, Karimi-Nejad A, Moskopp D, Schultheiss R, et al. “Ultrahigh” dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group. Zentralbl Neurochir. 1994;55(3):135–43.PubMedGoogle Scholar
  26. 26.
    Ghajar J, Hariri RJ, Narayan RK, Iacono LA, Firlik K, Patterson RH. Survey of critical care management of comatose, head-injured patients in the United States. Crit Care Med. 1995;23(3):560–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Young W. NASCIS. National Acute Spinal Cord Injury Study. J Neurotrauma. 1990;7(3):113–4. PubMed PMID: 2258941.Google Scholar
  28. 28.
    Andres-Cano P, Andres-Garcia JA, Alvarez-Galovich L. Corticosteroid therapy for acute spinal cord injury: the NASCIS controversy. Revista espanola de cirugia ortopedica y traumatologia. 2015;59(1):69–70. PubMed PMID: 25048274. Uso de corticoides tras la lesion medular aguda: la controversia NASCIS.Google Scholar
  29. 29.
    Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321–8. PubMed PMID: 15474134.Google Scholar
  30. 30.
    Green BA, Eismont FJ, O’Heir JT. Spinal cord injury–a systems approach: prevention, emergency medical services, and emergency room management. Crit Care Clin. 1987;3(3):471–93.PubMedGoogle Scholar
  31. 31.
    Ackery A, Tator C, Krassioukov A. A global perspective on spinal cord injury epidemiology. J Neurotrauma. 2004;21(10):1355–70.CrossRefPubMedGoogle Scholar
  32. 32.
    Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. The New England journal of medicine. 1990;322(20):1405–11.CrossRefPubMedGoogle Scholar
  33. 33.
    Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA. 1984;251(1):45–52.CrossRefPubMedGoogle Scholar
  34. 34.
    Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277(20):1597–604.CrossRefPubMedGoogle Scholar
  35. 35.
    Keane JR, Baloh RW. Posttraumatic cranial neuropathies. Neurol Clin. 1992;10(4):849–67.PubMedGoogle Scholar
  36. 36.
    Coello AF, Canals AG, Gonzalez JM, Martin JJ. Cranial nerve injury after minor head trauma. J Neurosurg. 2010;113(3):547–55.CrossRefPubMedGoogle Scholar
  37. 37.
    Jin H, Wang S, Hou L, Pan C, Li B, Wang H, et al. Clinical treatment of traumatic brain injury complicated by cranial nerve injury. Injury. 2010;41(9):918–23.CrossRefPubMedGoogle Scholar
  38. 38.
    Bhatoe HS. Blepharocele after head injury. Skull base: official journal of North American Skull Base Society [et al]. 2002;12(2):73–6. PubMed PMID: 17167651. Pubmed Central PMCID: 1656920.Google Scholar
  39. 39.
    Anderson RL, Panje WR, Gross CE. Optic nerve blindness following blunt forehead trauma. Ophthalmology. 1982;89(5):445–55.CrossRefPubMedGoogle Scholar
  40. 40.
    Spoor TC, Hartel WC, Lensink DB, Wilkinson MJ. Treatment of traumatic optic neuropathy with corticosteroids. Am J Ophthalmol. 1990;110(6):665–9.CrossRefPubMedGoogle Scholar
  41. 41.
    Cook MW, Levin LA, Joseph MP, Pinczower EF. Traumatic optic neuropathy. A meta-analysis. Arc Otolaryngol Head Neck Surg. 1996;122(4):389–92. PubMed PMID: 8600923.Google Scholar
  42. 42.
    Ropposch T, Steger B, Meco C, Emesz M, Reitsamer H, Rasp G, et al. The effect of steroids in combination with optic nerve decompression surgery in traumatic optic neuropathy. The Laryngoscope. 2013;123(5):1082–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, et al. Early treatment with prednisolone or acyclovir in Bell’s palsy. New Engl J Med. 2007;357(16):1598–607.CrossRefPubMedGoogle Scholar
  44. 44.
    Nash JJ, Friedland DR, Boorsma KJ, Rhee JS. Management and outcomes of facial paralysis from intratemporal blunt trauma: a systematic review. The Laryngoscope. 2010;120(Suppl 4):S214.CrossRefPubMedGoogle Scholar
  45. 45.
    Hurlbert RJ, Hadley MN, Walters BC, Aarabi B, Dhall SS, Gelb DE, et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery. 2013;72(Suppl 2):93–105.CrossRefPubMedGoogle Scholar
  46. 46.
    George ER, Scholten DJ, Buechler CM, Jordan-Tibbs J, Mattice C, Albrecht RM. Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am Surgeon. 1995;61(8):659–63; discussion 63-4. PubMed PMID: 7618802.Google Scholar
  47. 47.
    Prendergast MR, Saxe JM, Ledgerwood AM, Lucas CE, Lucas WF. Massive steroids do not reduce the zone of injury after penetrating spinal cord injury. The Journal of trauma. 1994;37(4):576–9; discussion 9-80. PubMed PMID: 7932887.Google Scholar
  48. 48.
    Gerndt SJ, Rodriguez JL, Pawlik JW, Taheri PA, Wahl WL, Micheals AJ, et al. Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma. 1997;42(2):279–84.CrossRefPubMedGoogle Scholar
  49. 49.
    Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine. 2001;26(4):426–30.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of NeurosurgeryUW Hospital and ClinicsMadisonUSA

Personalised recommendations